James M. Salhany

Kinetics of Reaction of Nitrite with Deoxy Hemoglobin after Rapid Deoxygenation or Predeoxygenation by Dithionite Measured in Solution and Bound to the Cytoplasmic Domain of Band 3 (SLC4A1)

The reaction of deoxyhemoglobin with nitrite was characterized in the presence of dithionite using hemoglobin in solution or bound to the cytoplasmic domain of band 3 (CDB3). Deoxyhemoglobin was generated by predeoxygenation (nitrogen flushing followed by addition of dithionite), or transiently, by rapidly mixing oxyhemoglobin with nitrite and dithionite simultaneously. Wavelength-dependent kinetic studies confirmed the formation of nitrosyl hemoglobin. Furthermore, the rate of reaction was independent of dithionite concentration, indicating that dithionite does not reduce nitrite to nitric oxide directly. Model simulation studies showed that superoxide anion generated by dithionite reduction of molecular oxygen was not a factor in the reaction kinetics. CDB3-bound hemoglobin reacted faster with nitrite than did hemoglobin in solution. This difference was most pronounced for predeoxygenated hemoglobin and least pronounced for rapidly deoxygenated hemoglobin. The smaller difference observed in the rapid deoxygenation experiment was associated with much faster kinetics compared to the predeoxygenation experiment. Model simulation studies showed, and literature evidence indicates, that faster kinetics in the rapid deoxygenation experiment were related to the initial presence of R-state Hb(II)O 2 alphabeta dimers, both in dilute solution and when bound to CDB3. Thus, rapidly deoxygenated CDB3-bound hemoglobin alphabeta dimers react 5-fold faster with nitrite than predeoxygenated tetrameric hemoglobin in solution. Faster nitrite reductase kinetics for CDB3-bound hemoglobin suggests the possibility of preferential nitric oxide generation at the inner surface of the erythrocyte membrane, thus coupling the release of oxygen from hemoglobin to the production and successful release of nitric oxide from the erythrocyte, and the regulation of blood flow.

Identification of the hemoglobin binding sites on the inner surface of the erythrocyte membrane.

The hemoglobin binding sites on the inner surface of the erythrocyte membrane were identified by measuring the fraction of hemoglobin released following selective proteolytic or lipolytic enzyme digestion. In addition, binding stoichiometry to and fractional hemoglobin release from inside-out vesicle preparations of human and rabbit membranes were compared since rabbit membranes differ significantly from human membranes only in that they lack glycophorin. Our results show that rabbit inside-out vesicles bind about 65% less human or rabbit hemoglobin under conditions of optimal and stoichiometric binding, despite being otherwise similar in composition. We suggest that this difference is either directly or indirectly due to the absence of glycophorin in rabbit membranes. Further supportive evidence includes demonstrating (a) that neuraminidase treatment of human membranes did not affect hemoglobin binding and (b) that reconstitution of isolated glycophorin into phospholipid vesicles increased the hemoglobin binding capacity in a manner proportional to the fraction of glycophorin molecules oriented with their cytoplasmic sides exposed to the exterior of the vesicle. Proteolysis of human inside-out vesicles either before or after addition of hemoglobin reduced the binding capacity by about 25%. This is consistent with the known proportion of total hemoglobin binding sites involving band 3 protein and the selective lability of the cytoplasmic aspect of band 3 protein to proteolysis. Phospholipid involvement in hemoglobin binding was determined using various phospholipase C preparations which differ in their reactivity profiles. Approximately 38% of the bound hemoglobin was released upon cleavage of phospholipid headgroups. These results suggest that the predominant sites of binding for hemoglobin on the inner surface of the red cell membrane are the two major integral membrane glycoproteins.

Lipid-mediated impairment of normal energy metabolism in the isolated perfused diabetic rat heart studied by phosphorus-31 NMR and chemical extraction

The relationship between extracellular palmitate and the accumulation of long-chain fatty-acyl coenzyme A with that of high-energy phosphate metabolism was investigated in the isolated perfused diabetic rat heart. Hearts were perfused with a glucose/albumin buffer supplemented with 0, 0.5, 1.2 or 2.0 mM palmitate. 31P-NMR was used to analyze phosphocreatine and ATP metabolism during 1 h of constant-flow recirculation perfusion. At the end of perfusion, frozen samples were taken for chemical analysis of high-energy phosphates and the free and acylated fractions of coenzyme A and carnitine. Perfusion of diabetic hearts with palmitate, unlike control hearts, caused a time-dependent and concentration-dependent reduction in ATP, despite normal and constant phosphocreatine. Concentrations of acid-soluble coenzyme A, long-chain-acyl coenzyme A and total tissue coenzyme A were elevated in palmitate-perfused diabetic hearts, while the total tissue carnitine pool was decreased. Increases in long-chain-acyl coenzyme A correlated with the reduction in myocardial ATP. This reduction in ATP could not be adequately explained by alterations in heart rate, perfusion pressure or vascular resistance.

Salient effects of l-carnitine on adenine-nucleotide loss and coenzyme A acylation in the diabetic heart perfused with excess palmitic acid: A phosphorus-31 NMR and chemical extract study

The beneficial effects of L-carnitine perfusion on energy metabolism and coenzyme A acylation were studied in isolated hearts from control and diabetic rats. All hearts were perfused at a constant flow rate with a glucose/albumin buffer which contained 2.0 mM palmitate. 31P-NMR was utilized to assess sequential phosphocreatine and ATP metabolism during 1 h of recirculation perfusion. L-Carnitine (5.0 mM final concentration) was added after 12 min of baseline recirculation perfusion. Frozen samples were taken after 1 h of recirculation perfusion for spectrophotometric analysis of high-energy phosphates and the free and acylated fractions of coenzyme A. L-Carnitine perfusion of diabetic hearts attenuated or prevented the reduction of ATP observed in untreated diabetic hearts. It also attenuated the accumulation of long-chain fatty-acyl coenzyme A. Although L-carnitine improved myocardial function in diabetic hearts, this was independent of any direct effect on physiological indices. Thus, the salutory effect of acute perfusion with L-carnitine on energy metabolism in the isolated perfused diabetic rat heart appears to be a direct effect on lipid metabolism.

Spectral and oxygen-release kinetic properties of human hemoglobin bound to the cytoplasmic fragment of band 3 protein in solution

Binding of the cytoplasmic fragment of band 3 protein to oxyhemoglobin in solution caused a spectral change in the absorbance of the hemoglobin beta chain at a ratio of one monomer of band 3 protein per alpha beta dimer of hemoglobin. This spectral change was reversed at higher ratios of cytoplasmic fragment to hemoglobin. The unusual dependence on protein concentration was interpreted as indicating the formation of higher aggregates of the complex between hemoglobin and the cytoplasmic fragment of band 3 protein. Oxygen-release kinetic measurements also showed marked changes as a function of the concentration of the cytoplasmic fragment of band 3 protein. The higher ratio mixture had significantly different kinetic properties as compared with the lower ratio one, which in turn was different from oxyhemoglobin in solution. The significance of the formation of aggregates of band 3 protein containing oxyhemoglobin dimers is discussed in context with evidence suggesting that band 3 protein may exist as an equilibrium mixture of tetramers and dimers in the membrane.

Gel filtration chromatographic studies of the isolated membrane domain of band 3

We have investigated the oligomeric state of the membrane domain of band 3 (MDB3) in non-ionic detergent solution using Sepharose CL-4B gel filtration chromatography to study the hydrodynamic properties of the protein as a function of its concentration. The studies were performed in a C12E9 (polyoxyethylene-9-lauryl ether) buffer containing phosphatidylcholine and sodium chloride, which significantly slow a dilution-induced band 3 conformational change, and an associated aggregation process. Under these conditions native MDB3 eluted predominantly as a single Gaussian peak with a Stokes radius of 76 +/- 14 A, at all protein concentrations studies between 0.2 and 12 microM. This value agrees with the calculated Stokes radius (74 A) determined from the crystal structure of the MDB3 dimer. The Stokes radius of the MDB3 monomer was obtained experimentally by treating native MDB3 with 0.5% SDS, and exchanging the SDS for C12E9 on the Sepharose column. SDS-treated MDB3 showed two peaks whose ratio was strongly dependent on applied protein concentration. The peak representing the largest material had a Stokes radius of 69.7 +/- 14 A, which is essentially the same as the native MDB3 dimer. The peak representing the smaller material had a Stokes radius of 36 +/- 9 A, and was assigned as the MDB3 monomer in C12E9. Evidence is discussed which indicates that the C12E9 monomer specifically self-associates to form a functional MDB3 dimer. We conclude that native MDB3 exists as a stable dimer in mixed micellar solutions composed of C12E9 and phosphatidylcholine, and that the dimer can be dissociated to monomers only by denaturation.

Quantitative analysis of the kinetics of stilbenedisulfonate binding to band 3

Abstract Stilbenedisulfonates are potent inhibitors of erythrocyte band 3 chloride/bicarbonate exchange. Band 3 exists as dimers and tetramers in situ, and each monomer binds one stilbenedisulfonate molecule. We determine: (a) whether stilbenedisulfonates exhibit cooperativity in reversible binding to the Band 3 dimer, and (b) whether stilbenedisulfonates directly compete with chloride. Stopped-flow and static fluorescence spectroscopy were used to measure the kinetics and equilibrium of DBDS (4,4′-dibenzamido-2,2′-stilbenedisulfonate) binding to isolated and membrane-bound Band 3. DBDS binding showed biphasic kinetic time courses which were consistent with a two step mechanism: Static binding studies showed no evidence for cooperativity, in agreement with the kinetic measurements. Chloride (150 mM) strongly affected the second step in the binding process by increasing k−2 about 20-fold, without significantly affecting k1, k−1 or k2. Our results indicate: (a) that DBDS binds independently to each monomer of the band 3 dimer, and (b) that DBDS is not competitive with chloride for binding to the transport site, but rather interacts with the transport site allosterically.

Reaction of nitrite with human fetal oxyhemoglobin: a model simulation study with implications for blood flow regulation in sickle cell disease (SCD).

Nitrite can react in parallel with adult oxy- and deoxy-hemoglobin (HbA), resulting in oxidative denitrosylation of nitrosyl-hemoglobin and rapid dissociation of nitric oxide. Here, simulation studies are presented using a new model to analyze data in the literature comparing the reaction of nitrite with isolated human oxy-HbA, oxy-fetal hemoglobin (oxy-HbF) and oxy-Hb Barts (a gamma-chain tetramer). The results show that the kinetic constant at the rate-limiting step is 25-fold larger for the reaction of human oxy-HbF, and 63-fold larger for oxy-Hb Barts both compared to oxy-HbA. This analysis suggests that red cells containing oxy-HbF (F-cells) should have accelerated oxidative denitrosylation. Thus, high levels of HbF present or induced in individuals homozygous for sickle cell disease may serve two functions: (a) the classical function, to directly inhibit polymerization of deoxy sickle hemoglobin, and (b) a novel function, enhanced vasodilation.

The isolated cytoplasmic domain of band 3 binds calcium at physiological salt concentration and neutral pH

Calcium is known to be a potent but partial intracellular inhibitor of band 3 anion exchange. Here we test the hypothesis that the cytoplasmic domain of band 3 (CDB3) contains a calcium binding site. Calcium binding to CDB3 was monitored by measuring the formation of the Aresenazo III-calcium complex at various constant CDB3 concentrations. These experiments were performed at physiological salt and neutral pH. The calcium-CDB3 dissociation constant was estimated to be less than or equal to 24 microM. We also found that the Arsenazo III-calcium complex binds to CDB3, while the free dye does not bind. We conclude that CDB3 contains a site which is capable of binding free calcium under physiological conditions. A specific role for this site in inhibition of band 3 anion exchange is suggested, but that role remains to be established.

A polymeric prostaglandin (PGBx) attenuates adenine nucleotide loss during global ischemia and improves myocardial function during reperfusion

Effects of a synthetic, prostaglandin (PGBx) on energy metabolism in isolated, guinea pig hearts were studied using P-31 nuclear magnetic resonance spectroscopy (NMR) or by direct chemical analysis. Polymeric prostaglandin (500 and 750 ng/ml) attenuated the reduction of ATP and adenine nucleotides during 35 min of total transient ischemia. This occurred despite the absence of any significant preischemic changes in heart rate, contractility or coronary vascular resistance. Preischemic perfusion with PGBx extended the time taken to reach 50% reduction in dP/dt following the first few seconds of ischemia. PGBx had no effect on the development of intracellular acidosis during ischemia. Reperfusion resulted in normalization of phosphocreatine but not ATP concentrations in control and experimental groups. Prostaglandin (750 ng/ml) caused faster and more complete recovery of left ventricular dP/dt following reperfusion. In contrast to untreated hearts, dP/dt in PGBx-treated hearts was significantly higher than preischemic values despite incomplete restoration (70% of control) of ATP levels. These results suggest that the beneficial effects of PGBx observed during myocardial ischemia are unrelated to functionally-induced alterations and that PGBx probably has some direct cellular effect on energy metabolism.